We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$16.1B
Cap. Flow %
-2.59%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.71%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GROW icon
2751
US Global Investors
GROW
$38.7M
$77K ﹤0.01%
26,700
INSG icon
2752
Inseego
INSG
$82.8M
$76K ﹤0.01%
9,010
+4,083
+83% +$61.3K
SLQT icon
2753
SelectQuote
SLQT
$127M
$76K ﹤0.01%
113,841
-41,729
-27% -$27.3K
VXRT
2754
DELISTED
Vaxart
VXRT
$76K ﹤0.01%
79,480
+4,176
+6% +$5.9K
BHIL
2755
DELISTED
Benson Hill, Inc.
BHIL
$76K ﹤0.01%
855
+96
+13% +$9.4K
PPSI
2756
Pioneer Power Solutions
PPSI
$33.1M
$75K ﹤0.01%
27,800
GOEV
2757
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$73K ﹤0.01%
128
+12
+10% +$7.36K
WKHS icon
2758
Workhorse Group
WKHS
$33.6M
$72K ﹤0.01%
16
+1
+7% +$6.89K
EXPR
2759
DELISTED
Express, Inc.
EXPR
$72K ﹤0.01%
3,533
+690
+24% +$16.5K
LPCN icon
2760
Lipocine
LPCN
$17M
$71K ﹤0.01%
10,862
AGPU
2761
Axe Compute Inc
AGPU
$92.8M
$70K ﹤0.01%
760
VBIV
2762
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$70K ﹤0.01%
5,997
-1,713
-22% -$30.2K
OMER icon
2763
Omeros
OMER
$1.25B
$69K ﹤0.01%
30,600
+13,000
+74% +$35.9K
EMKR
2764
DELISTED
Emcore Corp
EMKR
$69K ﹤0.01%
7,160
+2,400
+50% +$34.3K
DXLG icon
2765
Destination XL Group
DXLG
$33.2M
$68K ﹤0.01%
+10,135
New +$65K
GLDD
2766
DELISTED
Great Lakes Dredge & Dock
GLDD
$68K ﹤0.01%
11,423
+1,297
+13% +$9.12K
KULR icon
2767
KULR Technology Group
KULR
$142M
$68K ﹤0.01%
7,125
+2,737
+62% +$33.8K
TIO
2768
DELISTED
Tingo Group, Inc. Common Stock
TIO
$68K ﹤0.01%
82,300
+26,900
+49% +$22.6K
IQ icon
2769
iQIYI
IQ
$1.25B
$67K ﹤0.01%
12,700
NAGE
2770
Niagen Bioscience
NAGE
$244M
$66K ﹤0.01%
39,300
+16,800
+75% +$26.6K
WVVI icon
2771
Willamette Valley Vineyards
WVVI
$11.7M
$65K ﹤0.01%
10,850
AHT
2772
Ashford Hospitality Trust
AHT
$20.3M
$64K ﹤0.01%
1,439
+18
+1% +$1.16K
AXDX
2773
DELISTED
Accelerate Diagnostics
AXDX
$64K ﹤0.01%
9,028
CTOS icon
2774
Custom Truck One Source
CTOS
$2.45B
$64K ﹤0.01%
+10,057
New +$65.2K
ENZ
2775
DELISTED
Enzo Biochem, Inc.
ENZ
$64K ﹤0.01%
44,800

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.